drugset

drugset / Trial / NCT05041322

Improving Ventilatory Capacity in Those With Chronic High Level SCI

NCT05041322 ↗

Phase 2 Completed 13 enrolled Spaulding Rehabilitation Hospital

RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to find out if taking the drug Buspar will increase breathing capacity in individuals with spinal cord injuries.

Timeline

Start: 2020-11-29
Primary completion: 2024-11-01
Completion: 2024-11-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Buspirone	Small molecule	15 mg	Oral

Indications